Literature DB >> 31902643

Simultaneous cognate epitope recognition by bovine CD4 and CD8 T cells is essential for primary expansion of antigen-specific cytotoxic T-cells following ex vivo stimulation with a candidate Mycobacterium avium subsp. paratuberculosis peptide vaccine.

Gaber S Abdellrazeq1, Lindsay M Fry2, Mahmoud M Elnaggar1, John P Bannantine3, David A Schneider2, William M Chamberlin, Asmaa H A Mahmoud4, Kun-Taek Park5, Victoria Hulubei6, William C Davis7.   

Abstract

Studies in cattle show CD8 cytotoxic T cells (CTL), with the ability to kill intracellular bacteria, develop following stimulation of monocyte-depleted peripheral blood mononuclear cells (mdPBMC) with antigen presenting cells (APC, i.e. conventional dendritic cells [cDC] and monocyte-derived DC [MoDC]) pulsed with MMP, a membrane protein from Mycobacterium avium subsp. paratuberculosis (Map) encoded by MAP2121c. CTL activity was diminished if CD4 T cells were depleted from mdPBMC before antigen (Ag) presentation by APC, suggesting simultaneous cognate recognition of MMP epitopes presented by MHC I and MHC II molecules to CD4 and CD8 T cells is essential for development of CTL activity. To explore this possibility, studies were conducted with mdPBMC cultures in the presence of monoclonal antibodies (mAbs) specific for MHC class I and MHC class II molecules. The CTL response of mdPBMC to MMP-pulsed APC was completely blocked in the presence of mAbs to both MHC I and II molecules and also blocked in the presence of mAbs to either MHC I or MHC II alone. The results demonstrate simultaneous cognate recognition of Ag by CD4 and CD8 T cells is essential for delivery of CD4 T cell help to CD8 T cells to elicit development of CTL.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bovine; Cognate epitope recognition; Cytotoxicity; Dendritic cells; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Propidium monoazide; T cells; Vaccination

Year:  2020        PMID: 31902643     DOI: 10.1016/j.vaccine.2019.12.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification.

Authors:  Valdemir M Cardoso; Sheyla A H Paredes; Gilson Campani; Viviane M Gonçalves; Teresa C Zangirolami
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-13       Impact factor: 4.813

2.  Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach.

Authors:  Sk Injamamul Islam; Moslema Jahan Mou; Saloa Sanjida; Muhammad Tariq; Saad Nasir; Sarower Mahfuj
Journal:  Genomics Inform       Date:  2022-03-31

3.  Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2.

Authors:  Ahmad J Obaidullah; Mohammed M Alanazi; Nawaf A Alsaif; Hussam Albassam; Abdulrahman A Almehizia; Ali M Alqahtani; Shafi Mahmud; Saad Ahmed Sami; Talha Bin Emran
Journal:  RSC Adv       Date:  2021-05-19       Impact factor: 4.036

Review 4.  Ex vivo Platforms to Study the Primary and Recall Immune Responses to Intracellular Mycobacterial Pathogens and Peptide-Based Vaccines.

Authors:  William C Davis; Asmaa H Mahmoud; Gaber S Abdellrazeq; Mahmoud M Elnaggar; John L Dahl; Victoria Hulubei; Lindsay M Fry
Journal:  Front Vet Sci       Date:  2022-05-03

5.  Flow Cytometric Analysis of the Cytotoxic T-Cell Recall Response to Theileria parva in Cattle Following Vaccination by the Infection and Treatment Method.

Authors:  Mahmoud M Elnaggar; Donald P Knowles; William C Davis; Lindsay M Fry
Journal:  Vet Sci       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.